Recent Finacing
Recent Raise
Atossa Genetics develops and markets the MASCT System, a nipple-aspirate–based cytologic and molecular diagnostic platform used adjunctively with mammography to assess breast cancer risk and establish dedicated cytology/molecular labs.
Focus Areas
Total Raised
Funding round